Choreo LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.5M | Sell |
105,320
-171
| -0.2% | -$36.8K | 0.29% | 57 |
|
|
2026
Q1 | $22.9M | Sell |
105,491
-937
| -0.9% | -$208K | 0.28% | 62 |
|
|
2025
Q4 | $24.5M | Sell |
106,428
-2,572
| -2% | -$586K | 0.31% | 57 |
|
|
2025
Q3 | $25.2M | Buy |
109,000
+350
| +0.3% | +$71.3K | 0.33% | 57 |
|
|
2025
Q2 | $20.2M | Buy |
108,650
+487
| +0.5% | +$90.5K | 0.28% | 70 |
|
|
2025
Q1 | $22.7M | Buy |
108,163
+4,269
| +4% | +$830K | 0.35% | 57 |
|
|
2024
Q4 | $18.4M | Buy |
103,894
+20,938
| +25% | +$3.85M | 0.26% | 76 |
|
|
2024
Q3 | $16.3M | Buy |
82,956
+4,584
| +6% | +$856K | 0.24% | 78 |
|
|
2024
Q2 | $13.4M | Buy |
78,372
+51,597
| +193% | +$8.55M | 0.22% | 79 |
|
|
2024
Q1 | $4.87M | Sell |
26,775
-2,176
| -8% | -$375K | 0.13% | 104 |
|
|
2023
Q4 | $4.49M | Sell |
28,951
-655
| -2% | -$95.5K | 0.12% | 113 |
|
|
2023
Q3 | $4.41M | Buy |
29,606
+3,205
| +12% | +$471K | 0.16% | 82 |
|
|
2023
Q2 | $3.56M | Sell |
26,401
-31
| -0.1% | -$4.55K | 0.12% | 103 |
|
|
2023
Q1 | $4.21M | Buy |
26,432
+15,921
| +151% | +$2.43M | 0.15% | 95 |
|
|
2022
Q4 | $1.7M | Buy |
10,511
+19
| +0.2% | +$2.91K | 0.08% | 67 |
|
|
2022
Q3 | $1.41M | Buy |
10,492
+249
| +2% | +$35.7K | 0.08% | 69 |
|
|
2022
Q2 | $1.57M | Sell |
10,243
-666
| -6% | -$102K | 0.09% | 64 |
|
|
2022
Q1 | $1.77M | Buy |
10,909
+6
| +0.1% | +$872 | 0.09% | 67 |
|
|
2021
Q4 | $1.48M | Buy |
10,903
+50
| +0.5% | +$5.91K | 0.07% | 68 |
|
|
2021
Q3 | $1.17M | Buy |
10,853
+436
| +4% | +$49.8K | 0.06% | 79 |
|
|
2021
Q2 | $1.17M | Buy |
10,417
+1,495
| +17% | +$168K | 0.06% | 79 |
|
|
2021
Q1 | $965K | Buy |
8,922
+1,110
| +14% | +$119K | 0.06% | 86 |
|
|
2020
Q4 | $837K | Sell |
7,812
-110
| -1% | -$10.6K | 0.06% | 91 |
|
|
2020
Q3 | $694K | Sell |
7,922
-1,248
| -14% | -$117K | 0.06% | 91 |
|
|
2020
Q2 | $900K | Sell |
9,170
-400
| -4% | -$35.2K | 0.09% | 77 |
|
|
2020
Q1 | $729K | Buy |
9,570
+171
| +2% | +$14.6K | 0.09% | 85 |
|
|
2019
Q4 | $832K | Sell |
9,399
-1,288
| -12% | -$107K | 0.08% | 94 |
|
|
2019
Q3 | $809K | Sell |
10,687
-1,079
| -9% | -$74K | 0.09% | 90 |
|
|
2019
Q2 | $856K | Buy |
11,766
+155
| +1% | +$12.2K | 0.1% | 89 |
|
|
2019
Q1 | $936K | Buy |
11,611
+2,438
| +27% | +$199K | 0.11% | 84 |
|
|
2018
Q4 | $846K | Buy |
9,173
+682
| +8% | +$60K | 0.12% | 82 |
|
|
2018
Q3 | $803K | Sell |
8,491
-3,608
| -30% | -$342K | 0.11% | 92 |
|
|
2018
Q2 | $1.12M | Sell |
12,099
-4,082
| -25% | -$399K | 0.15% | 80 |
|
|
2018
Q1 | $1.53M | Sell |
16,181
-479
| -3% | -$52.6K | 0.18% | 73 |
|
|
2017
Q4 | $1.61M | Buy |
16,660
+130
| +0.8% | +$12.3K | 0.19% | 70 |
|
|
2017
Q3 | $1.47M | Sell |
16,530
-826
| -5% | -$62.9K | 0.19% | 73 |
|
|
2017
Q2 | $1.26M | Buy |
17,356
+3,733
| +27% | +$251K | 0.18% | 77 |
|
|
2017
Q1 | $888K | Buy |
13,623
+1,316
| +11% | +$82.7K | 0.13% | 92 |
|
|
2016
Q4 | $771K | Sell |
12,307
-2,933
| -19% | -$179K | 0.12% | 100 |
|
|
2016
Q3 | $961K | Buy |
15,240
+1,497
| +11% | +$96.9K | 0.17% | 78 |
|
|
2016
Q2 | $851K | Buy |
13,743
+1,076
| +8% | +$65.6K | 0.16% | 80 |
|
|
2016
Q1 | $724K | Buy |
12,667
+1,936
| +18% | +$108K | 0.15% | 79 |
|
|
2015
Q4 | $636K | Buy |
10,731
+118
| +1% | +$6.8K | 0.15% | 72 |
|
|
2015
Q3 | $577K | Buy |
10,613
+1,531
| +17% | +$99.7K | 0.15% | 71 |
|
|
2015
Q2 | $610K | Buy |
9,082
+98
| +1% | +$6.4K | 0.15% | 75 |
|
|
2015
Q1 | $526K | Buy |
8,984
+641
| +8% | +$38.7K | 0.13% | 83 |
|
|
2014
Q4 | $546K | Buy |
8,343
+155
| +2% | +$9.77K | 0.15% | 73 |
|
|
2014
Q3 | $473K | Buy |
8,188
+103
| +1% | +$5.72K | 0.14% | 70 |
|
|
2014
Q2 | $456K | Buy |
8,085
+44
| +0.5% | +$2.31K | 0.13% | 77 |
|
|
2014
Q1 | $413K | Buy |
+8,041
| New | +$406K | 0.12% | 81 |
|
Other funds holding ABBV
Choreo LLC's ABBV Position: Q2 2026 in Review
Choreo LLC reduced its AbbVie (ABBV) stake by 0.16% in Q2 2026, selling an estimated $36.8K and leaving 105,320 shares worth $26.5M. The position accounts for 0.29% of the portfolio, ranked #57.
Choreo LLC first reported a position in ABBV in Q1 2014 and has held it in 50 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Choreo LLC held 105,320 shares of AbbVie worth $26.5M as of Q2 2026.
- Choreo LLC sold 171 AbbVie shares in Q2 2026, an estimated $36.8K.
- AbbVie made up 0.29% of Choreo LLC's portfolio in Q2 2026, its #57 holding.
- Choreo LLC first reported a position in AbbVie in Q1 2014 and has held it in 50 quarters since.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.